A survival analysis of psychostimulant prescriptions in New South Wales from 1990 to 2010

M Lambert; Robert Reid; Brenton PROSSER; R Bussing

doi:10.1089/cap.2014.0151

A survival analysis of psychostimulant prescriptions in New South Wales from 1990 to 2010

M Lambert
, Robert Reid
, Brenton PROSSER
, R Bussing

Health Research Institute

Research output: Contribution to journal › Review article › peer-review

5 Citations (Scopus)

Abstract

Objective: Psychostimulant medication is considered a mainstay in the treatment of attention-deficit/hyperactivity disorder (ADHD); however, research suggests that the typical duration of medication treatment for children and youth may be

Original language	English
Pages (from-to)	475-481
Number of pages	7
Journal	Journal of Child and Adolescent Psychopharmacology
Volume	25
Issue number	6
DOIs	https://doi.org/10.1089/cap.2014.0151
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1089/cap.2014.0151

Cite this

@article{3adb1f549e394c538b76470068881f42,

title = "A survival analysis of psychostimulant prescriptions in New South Wales from 1990 to 2010",

abstract = "Objective: Psychostimulant medication is considered a mainstay in the treatment of attention-deficit/hyperactivity disorder (ADHD); however, research suggests that the typical duration of medication treatment for children and youth may be",

author = "M Lambert and Robert Reid and Brenton PROSSER and R Bussing",

year = "2015",

doi = "10.1089/cap.2014.0151",

language = "English",

volume = "25",

pages = "475--481",

journal = "Journal of Child and Adolescent Psychopharmacology",

issn = "1044-5463",

publisher = "Mary Ann Liebert Inc",

number = "6",

}

TY - JOUR

T1 - A survival analysis of psychostimulant prescriptions in New South Wales from 1990 to 2010

AU - Lambert, M

AU - Reid, Robert

AU - PROSSER, Brenton

AU - Bussing, R

PY - 2015

Y1 - 2015

N2 - Objective: Psychostimulant medication is considered a mainstay in the treatment of attention-deficit/hyperactivity disorder (ADHD); however, research suggests that the typical duration of medication treatment for children and youth may be

AB - Objective: Psychostimulant medication is considered a mainstay in the treatment of attention-deficit/hyperactivity disorder (ADHD); however, research suggests that the typical duration of medication treatment for children and youth may be

UR - https://www.scopus.com/pages/publications/84939177295

UR - https://www.mendeley.com/catalogue/18367c7e-03bd-3cd5-80e5-a26e6c8b39b6/

U2 - 10.1089/cap.2014.0151

DO - 10.1089/cap.2014.0151

M3 - Review article

SN - 1044-5463

VL - 25

SP - 475

EP - 481

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

IS - 6

ER -

A survival analysis of psychostimulant prescriptions in New South Wales from 1990 to 2010

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this